Scarica l'app Stockscreener
22.49
0.35%
-0.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché FMS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Fresenius Medical Care Ag Adr Borsa (FMS) Ultime notizie
Fresenius Medical Care stock (DE0005785802): Is chronic kidney disease demand strong enough to unloc - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Why Google Discover changes matter more now - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Is U.S. dialysis dominance still the key growth engine? - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Why U.S. dialysis demand now drives the real value test - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): Is U.S. dialysis dominance still the key growth lever? - AD HOC NEWS
Research in Brief: Immunosuppressive therapies in kidney transplant recipients - Fresenius Medical Care
Fresenius Medical Care Sets May 21, 2026 AGM With Dividend and New Buyback Mandate on Agenda - TipRanks
Fresenius Medical Care (NYSE: FMS) plans €1.49 dividend and renews 10% buyback mandate - Stock Titan
Fresenius Medical Care stock: What you should know now before buying - AD HOC NEWS
Supporting living donors through the Circle of Excellence - Fresenius Medical Care
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
Fresenius Medical Care stock advances FME Reignite strategy with Interwell Health investment amid st - AD HOC NEWS
10 New 5-Star Stocks This Week - Morningstar
Fresenius Medical Care publishes its Annual Report 2025: The power of care - Fresenius Medical Care
Advancing kidney care: Introducing high-volume hemodiafiltration to the U.S. - Fresenius Medical Care
Fresenius Medical Care Faces a Transition Year in 2026 on New Product Launch Activities - Morningstar
Fresenius Medical Care marks World Kidney Day and National Kidney Month - Fresenius Medical Care
Fresenius Medical Care's 2030 Ambition: Navigating a Pivotal Transition () - aktiencheck.de
Fresenius Medical Care: An Undervalued Stock to Buy Now and Hold for the Long Term - Morningstar
5 Undervalued Stocks That Crushed Q4 Earnings - Morningstar
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand - Finviz
Research in brief: Nocturnal home hemodialysis - Fresenius Medical Care
Fresenius Medical Care ADR earnings beat by $1.11, revenue topped estimates - Investing.com Australia
Fresenius Medical Care published Report on Form 20-F for fiscal year 2025 - Fresenius Medical Care
Fresenius Medical Care Q4 2025 slides: margin surge, flat 2026 outlook - Investing.com
Earnings call transcript: Fresenius Medical Care Q4 2025 beats EPS expectations - Investing.com
Fresenius Medical Care falls nearly 7% despite earnings beat - Investing.com South Africa
Fresenius Medical Care falls 7% after 2026 flat growth outlook and cost update - Investing.com
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band - Fresenius Medical Care
Uncovering Potential: Fresenius Medical Care's Earnings Preview - Sahm
Fresenius Can't Knock Out 401(k) Forfeiture Suit - Law360
Research in Brief: Hemodiafiltration and hospitalization burden in ESKD - Fresenius Medical Care
FedEx Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Allstate Upgraded, Amazon Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Statement from Fresenius Medical Care on Upcoming Winter Storm - Fresenius Medical Care
Annual Press Conference 2026 - Fresenius Medical Care
18 of the Best Stocks and ETFs to Buy Based on 2026 Expert Forecasts - Morningstar
6 New 5-Star Stocks - Morningstar
Research in Brief: Implementation of Online High-Volume Hemodiafiltration - Fresenius Medical Care
Goldman Sachs downgrades Fresenius Medical Care stock on 2026 headwinds By Investing.com - Investing.com South Africa
Goldman Sachs downgrades Fresenius Medical Care stock on 2026 headwinds - Investing.com
Reasons to Add Fresenius Medical Stock to Your Portfolio Now - Finviz
Fresenius Medical Care accelerates second tranche of share buyback - Investing.com
Fresenius Medical Care accelerates second tranche of share buyback By Investing.com - Investing.com India
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned - Fresenius Medical Care
Finding purpose and perseverance: A dialysis nurse’s quiet heroism - Fresenius Medical Care
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now - Finviz
Fresenius Medical Care names Charles Hugh-Jones as new global CMO By Investing.com - Investing.com South Africa
Fresenius Medical Care names Charles Hugh-Jones as new global CMO - Investing.com India
1.59%
7.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):